Amedisys Reports First Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Amedisys (AMED) Misses Q1 EPS by 1c; Withdraws Outlook
May 6, 2020 4:26 PM EDTAmedisys (NASDAQ: AMED) reported Q1 EPS of $0.96, $0.01 worse than the analyst estimate of $0.97. Revenue for the quarter came in at $491.7 million versus the consensus estimate of $504.85 million.
Paul B. Kusserow, President and Chief Executive Officer stated, I am very proud of our first quarter results... More



